The work from Garvin and colleagues builds on a study that proposed that depletion of ACE2 in COVID-19 patients, and upregulation of B1/B2 receptors, might lead to vascular leakage in the lungs leading to angio-oedema [86]. Here, ACE2 is linked to COVID-19.